Related Experiment Video
Updated: Jan 19, 2026
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Abstract:
The Genomics of Drug Sensitivity in Cancer project recently added 4 years of additional data to a large-scale database designed to identify predictive biomarkers for cancer therapies. Freely available online, these data are driving research on the relationship between genomic features and drug responses to better tailor treatment to individual patients.
Insights
The Genomics of Drug Sensitivity in Cancer project expanded its database with four years of new data. This resource aids in discovering biomarkers to personalize cancer drug treatments for individual patients.
Area of Science:
- Genomics
- Cancer Research
- Pharmacology
Background:
- The Genomics of Drug Sensitivity in Cancer project maintains a large-scale database.
- This database aims to identify predictive biomarkers for cancer therapies.
Purpose of the Study:
- To incorporate four additional years of data into the existing database.
- To drive research on genomic features and drug responses.
- To facilitate personalized cancer treatment strategies.
Main Methods:
- Data aggregation and curation from the Genomics of Drug Sensitivity in Cancer project.
- Analysis of genomic data in relation to drug sensitivity.
Main Results:
- Addition of four years of comprehensive data to the project's database.
- Enhanced ability to explore genotype-phenotype correlations in cancer drug response.
Conclusions:
- The expanded database is a valuable, freely available resource for cancer research.
- These data will advance the identification of biomarkers for tailored cancer therapies.
